Deutsche Bank
SVA

Deutsche Bank’s Sinovac Biotech, Ltd SVA Stock Holding History

Deutsche Bank’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-73,337
Closed -$547K – 5786
2018
Q2 		$547K Sell
73,337
-105,129
-59% -$827K ﹤0.01% 3802
2018
Q1 		$1.54M Sell
178,466
-66,862
-27% -$551K ﹤0.01% 3041
2017
Q4 		$1.93M Buy
245,328
+41,114
+20% +$308K ﹤0.01% 2749
2017
Q3 		$1.44M Buy
204,214
+179,975
+743% +$1.23M ﹤0.01% 2770
2017
Q2 		$163K Buy
24,239
+9,230
+61% +$50.6K ﹤0.01% 4035
2017
Q1 		$86K Sell
15,009
-69,401
-82% -$402K ﹤0.01% 3993
2016
Q4 		$498K Buy
84,410
+1,180
+1% +$7.1K ﹤0.01% 3174
2016
Q3 		$491K Sell
83,230
-980
-1% -$5.76K ﹤0.01% 3201
2016
Q2 		$499K Sell
84,210
-70,406
-46% -$432K ﹤0.01% 3283
2016
Q1 		$987K Buy
154,616
+8,749
+6% +$52.5K ﹤0.01% 2818
2015
Q4 		$833K Sell
145,867
-6,502
-4% -$35K ﹤0.01% 2999
2015
Q3 		$773K Sell
152,369
-25,328
-14% -$134K ﹤0.01% 3105
2015
Q2 		$932K Buy
177,697
+11,389
+7% +$60.2K ﹤0.01% 3013
2015
Q1 		$824K Buy
166,308
+8,325
+5% +$41K ﹤0.01% 2986
2014
Q4 		$825K Buy
157,983
+8,884
+6% +$45.3K ﹤0.01% 3339
2014
Q3 		$716K Buy
149,099
+16,635
+13% +$89.3K ﹤0.01% 3250
2014
Q2 		$746K Sell
132,464
-3,412
-3% -$20.7K ﹤0.01% 3184
2014
Q1 		$977K Sell
135,876
-49,071
-27% -$325K ﹤0.01% 2874
2013
Q4 		$1.13M Sell
184,947
-172,105
-48% -$1.04M ﹤0.01% 2589
2013
Q3 		$2.13M Buy
357,052
+168,707
+90% +$806K ﹤0.01% 2447
2013
Q2 		$738K Buy
+188,345
New +$701K ﹤0.01% 2903

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Deutsche Bank's SVA Position: Q3 2018 in Review

Deutsche Bank sold out of Sinovac Biotech, Ltd (SVA) in Q3 2018, closing a stake of 73,337 shares — an estimated $547K sold.

Deutsche Bank first reported a position in SVA in Q2 2013 and held it in 21 quarters. The position peaked at $2.13M in Q3 2013. 28 funds tracked by Wall St. Rank hold SVA as of Q3 2018.

  • Deutsche Bank reported no remaining Sinovac Biotech, Ltd position as of Q3 2018 after selling out during the quarter.
  • Deutsche Bank sold 73,337 Sinovac Biotech, Ltd shares in Q3 2018, an estimated $547K.
  • Deutsche Bank first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 21 quarters.
  • Deutsche Bank's Sinovac Biotech, Ltd position peaked at $2.13M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2018.

Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.